Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 256 Next >>

Filter Applied: epidemiology of neurology (Click to remove)

Surgical Treatment and Risk of Sporadic Creutzfeldt-Jakob Disease:A Case-Control Study
Lancet 353:693-697, Collins,S.,et al, 1999

Transmissible Spongiform Encephalopathy in the 21st Century: Neuroscience for the Clinical Neurologist
Neurol 70:713-722, Brown,P., 2008

Iatrogenic Creutzfeldt-Jakob Disease: The Waning of an Era
Neurol 67:389-393, Brown,P.,et al, 2006

Transmissible Spongiform Encephalopathies
Lancet 363:51-61, Collins,S.J.,et al, 2004

Bovine Spongiform Encephalopathy in the United States - An Epidemiologist's View
NEJM 350:539-542, Donnelly,C.A., 2004

Neurodegenerative Diseases and Prions
NEJM 344:1516-1526,1548, Prusiner,S.B., 2001

Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease
BMJ 322:841-844, Brown,P., 2001

Variant Creutzfeldt-Jakob Disease
Lancet 354:317-323, Collinge,J., 1999

Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998

Creutzfeldt-Jakob Disease in Pituitary Growth Hormone Recipients in the United States
JAMA 265:880-884, Fradkin,J.E.,et al, 1991

The Epidemiology of Creutzfeldt-Jakob Disease:Conclusion of a 15-year Investigation in France & Review of the Literature
Neurol 37:895-904, Brown,P.,et al, 1987

Iatrogenic Creutzfeldt-Jakob Disease
Neurol 37:1520-1522, Rappaport,E.B., 1987

Kuru in the 21st Century--An Acquired Human Prion Disease With Very Long Incubation Periods
Lancet 367:2068-2074, Collinge,J.,et al, 2006

A New Variant of Creutzfeldt-Jakob Disease in the UK
Lancet 347:921-925, 915, 916, 91796., Will,R.G.,et al, 1996

Creutzfeldt-Jakob Disease and Bovine Spongiform Encephalopathy:Any Connection?
BMJ 311:1415-1421, Almond,J.W., 1995

Human Immunodeficiency Virus (HIV) Infection and the Nervous System:Report from The American Academy of Neurology AIDS Task Force
Neurol 39:119-122, , 1989

Creutzfeldt-Jakob Disease:Patterns of Worldwide Occurrence & the Significance of Familial & Sporadic Clustering
Ann Neurol 5:177-188, Masters,C.L.,et al, 1979

Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis
Ann Neurol 92:201-212, Lindgren, U.,et al, 2022

Neuromyelitis Optica Spectrum Disorder
NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022

What All Physicians Need to Know About the Polio Resurgence in New York State
JAMA online e1-e3, Larkin, H., 2022

Functional Neurological Disorders
Neurologist 27:276-289, Mishra, A. & Pandey, S., 2022

Spontaneous Subarachnoid Haemorrhage
Lancet 400:846-862, Claassen, J. & Park, S., 2022

Alzheimers Disease
Lancet 397:1577-1590, Scheltens, P.,et al, 2021

Changes in Stroke Hospital Care During the COVID-19 Pandemic
Stroke 52:3651-3660, Katsanos, A.H.,et al, 2021

Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020

Migraine
NEJM 383:1866-1876, Ashina, M., 2020

Muscular Dystrophies
Lancet 394:2025-2038, Mercuri, E.,et al, 2019

Central Nervous System Infections Due to Coccidioidomycosis
J Fungi 5:2-12, Jackson, N.R.,et al, 2019

Multiple Sclerosis
NEJM 378:169-180, Reich, D.S.,et al, 2018

Neuroimaging Findings of Zika Virus-Associated Neurologic Complications in Adults
AJNR 39:1967-1974, Hygino da Cruz, L.C.,et al, 2018

Stroke
Lancet 389:641-654, Hankey, G.J., 2017

Non-Specific Low Back Pain
Lancet 389:736-747, Maher, C.,et al, 2017

Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches
Front Neurol doi:10.3389/fneur.2017.00472, Velazquez-Perez, L.C.,et al, 2017

Infective Endocarditis
Lancet 387:882-893, Cahill, T.J. & Prendergast, B.D., 2016

Zika Virus
NEJM 374:1552-1563, Petersen, L.R.,et al, 2016

Zika Virus as an Emerging Global Pathogen
JAMA Neurol 73:875-879, Beckham, J.D.,et al, 2016

Acute Flaccid Myelitis; A Clinical Review of US Cases 2012-2015
Ann Neurol 80:326-338, Messacar, K.,et al, 2016

Global and Regional Effects of Potentially Modifiable Risk Factors Associated with Acute Stroke in 32 Countries (INTERSTROKE): A Case-Control Study
Lancet 388:761-775,733, ODonnell M.J.,et al, 2016

Zika Virus: An Emergent Neuropathological Agent
Ann Neurol 80:479-489, White, M.K.,et al, 2016

Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016

Emerging Cases of Powassan Virus Encephalitis in New England:Clinical Presentation, Imaging, and Review of the Literature
CID 62:707-713, Piantadosi,A.,et al, 2016

Advantages and Limitations of Teleneurology
JAMA Neurol 72:349-354, Wechsler, L.R., 2015

Cyclical Konzo Epidemics and Climate Variability
Ann Neurol 77:371-380, Oluwole, O.S.A., 2015

Brain Death Declaration
Neurol 84:1870-1879, Wahlster, S.,et al, 2015

Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course
AJNR 36:1392-1399, Miller, T.R.,et al, 2015

Non-Alzheimers Dementia 3 Vascular Dementia
Lancet 386:1698-1706, OBrien, J.T. & Thomas, A., 2015

Bells Palsy: Aetiology, Clinical Features and Multidisciplinary Care
JNNP 86:1356-1361, Eviston, T.J.,et al, 2015

Drug Treatment of Epilepsy in Adults
BMJ 348:g2546, Schmidt, D. & Schachter, S.C., 2014

Chronic Migraine
BMJ 348:g141b, Schwedt, T.J., 2014



Showing articles 0 to 50 of 256 Next >>